A Spanish Cost-utility Analysis of Nab-paclitaxel Compared to Conventional Paclitaxel Monotherapy for Pretreated Metastatic Breast Cancer: Results From the COSTABRAX Study

dc.contributor.author	López López, Rafael
dc.date.accessioned	2017-06-07T07:20:41Z
dc.date.available	2017-06-07T07:20:41Z
dc.date.issued	2012
dc.identifier.issn	0959-8049
dc.identifier.uri	http://hdl.handle.net/20.500.11940/5370
dc.language.iso	eng
dc.title	A Spanish Cost-utility Analysis of Nab-paclitaxel Compared to Conventional Paclitaxel Monotherapy for Pretreated Metastatic Breast Cancer: Results From the COSTABRAX Study
dc.type	Publicación de congreso
dc.authorsophos	Alba, E
dc.authorsophos	Ciruelos, E
dc.authorsophos	Lopez, R
dc.authorsophos	Vega, J M L
dc.authorsophos	Lluch, A
dc.authorsophos	Martin, M
dc.authorsophos	Rovira, P S
dc.authorsophos	Segui, M A
dc.authorsophos	Liria, M R
dc.authorsophos	Perez, F
dc.identifier.isi	302804600264
dc.identifier.sophos	8714
dc.issue.number	SUPPL 1
dc.journal.title	EUROPEAN JOURNAL OF CANCER
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago - Complexo Hospitalario Universitario de Santiago::Oncoloxía médica
dc.page.initial	S117
dc.page.final	S117
dc.rights.accessRights	openAccess
dc.typesophos	Comunicaciones a congresos
dc.volume.number	48

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.